Dana Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.22M | Sell |
9,640
-4
| -0% | -$527 | 0.03% | 396 |
|
|
2026
Q1 | $1.34M | Hold |
9,644
| – | – | 0.04% | 370 |
|
|
2025
Q4 | $1.18M | Hold |
9,644
| – | – | 0.03% | 380 |
|
|
2025
Q3 | $1.07M | Hold |
9,644
| – | – | 0.03% | 380 |
|
|
2025
Q2 | $1.07M | Sell |
9,644
-235
| -2% | -$25K | 0.04% | 379 |
|
|
2025
Q1 | $1.11M | Sell |
9,879
-75
| -0.8% | -$7.74K | 0.04% | 368 |
|
|
2024
Q4 | $919K | Hold |
9,954
| – | – | 0.03% | 396 |
|
|
2024
Q3 | $835K | Sell |
9,954
-200
| -2% | -$15.3K | 0.03% | 402 |
|
|
2024
Q2 | $697K | Buy |
10,154
+31
| +0.3% | +$2.07K | 0.02% | 409 |
|
|
2024
Q1 | $742K | Buy |
10,123
+110
| +1% | +$8.46K | 0.02% | 406 |
|
|
2023
Q4 | $811K | Buy |
10,013
+795
| +9% | +$61.9K | 0.04% | 273 |
|
|
2023
Q3 | $691K | Buy |
9,218
+586
| +7% | +$45.1K | 0.04% | 276 |
|
|
2023
Q2 | $665K | Hold |
8,632
| – | – | 0.03% | 283 |
|
|
2023
Q1 | $716K | Buy |
8,632
+48
| +0.6% | +$3.98K | 0.04% | 277 |
|
|
2022
Q4 | $737K | Buy |
8,584
+450
| +6% | +$35.6K | 0.04% | 268 |
|
|
2022
Q3 | $502K | Sell |
8,134
-76
| -0.9% | -$4.79K | 0.03% | 298 |
|
|
2022
Q2 | $507K | Buy |
+8,210
| New | +$508K | 0.03% | 303 |
|
|
2019
Q3 | – | Sell |
-3,209
| Closed | -$217K | – | 270 |
|
|
2019
Q2 | $217K | Buy |
+3,209
| New | +$211K | 0.01% | 272 |
|
|
2018
Q2 | – | Sell |
-26,924
| Closed | -$2.03M | – | 275 |
|
|
2018
Q1 | $2.03M | Buy |
26,924
+73
| +0.3% | +$5.8K | 0.09% | 175 |
|
|
2017
Q4 | $1.92M | Sell |
26,851
-1,428
| -5% | -$108K | 0.08% | 183 |
|
|
2017
Q3 | $2.29M | Buy |
28,279
+220
| +0.8% | +$16.8K | 0.11% | 164 |
|
|
2017
Q2 | $1.99M | Sell |
28,059
-1,939
| -6% | -$129K | 0.09% | 186 |
|
|
2017
Q1 | $2.04M | Sell |
29,998
-28,700
| -49% | -$2.02M | 0.09% | 185 |
|
|
2016
Q4 | $4.2M | Sell |
58,698
-462
| -0.8% | -$34.3K | 0.2% | 111 |
|
|
2016
Q3 | $4.68M | Sell |
59,160
-12,570
| -18% | -$1.02M | 0.22% | 96 |
|
|
2016
Q2 | $5.98M | Sell |
71,730
-323,212
| -82% | -$28.7M | 0.27% | 94 |
|
|
2016
Q1 | $36.3M | Buy |
394,942
+360,124
| +1,034% | +$32.5M | 1.64% | 10 |
|
|
2015
Q4 | $34.8K | Sell |
34,818
-351,940
| -91% | -$36.6M | 1.69% | 11 |
|
|
2015
Q3 | $38M | Buy |
386,758
+19,269
| +5% | +$2.14M | 1.79% | 8 |
|
|
2015
Q2 | $43M | Buy |
367,489
+63,808
| +21% | +$6.97M | 2.02% | 3 |
|
|
2015
Q1 | $29.8M | Sell |
303,681
-78,026
| -20% | -$7.92M | 1.45% | 23 |
|
|
2014
Q4 | $36M | Buy |
381,707
+139,589
| +58% | +$14.4M | 1.46% | 18 |
|
|
2014
Q3 | $25.8M | Buy |
242,118
+234,922
| +3,265% | +$23M | 1.49% | 20 |
|
|
2014
Q2 | $597K | Sell |
7,196
-547
| -7% | -$42.6K | 0.03% | 210 |
|
|
2014
Q1 | $549K | Sell |
7,743
-922
| -11% | -$72.3K | 0.03% | 214 |
|
|
2013
Q4 | $651K | Buy |
+8,665
| New | +$603K | 0.04% | 187 |
|
Other funds holding GILD
Dana Investment Advisors's GILD Position: Q2 2026 in Review
Dana Investment Advisors reduced its Gilead Sciences (GILD) stake by 0.04% in Q2 2026, selling an estimated $527 and leaving 9,640 shares worth $1.22M. The position accounts for 0.03% of the portfolio, ranked #396.
Dana Investment Advisors first reported a position in GILD in Q4 2013 and has held it in 36 quarters since. The position peaked at $43M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Dana Investment Advisors held 9,640 shares of Gilead Sciences worth $1.22M as of Q2 2026.
- Dana Investment Advisors sold 4 Gilead Sciences shares in Q2 2026, an estimated $527.
- Gilead Sciences made up 0.03% of Dana Investment Advisors's portfolio in Q2 2026, its #396 holding.
- Dana Investment Advisors first reported a position in Gilead Sciences in Q4 2013 and has held it in 36 quarters since.
- Dana Investment Advisors's Gilead Sciences position peaked at $43M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.